|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Discorvery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2(SGLT2) inhibitor for the treatment of type 2 diabetes显示文摘 | Meng W Ellsworth BA Nirschl AA | 2008 | J Med Chem2008，51，5： | 1 |
| 2 | Discovery of dapagliflozin:a potent,selective renal sodium-dependent glucose cotransporter 2 (SGLT2)inhibitor for the treatment of type 2 diabetes显示文摘 | Meng W Ellsworth BA Nirschl AA | 2008 | J Med Chem2008，51，5： | 1 |
| 3 | Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes 显示文摘 | Meng W Ellsworth BA Nirschl AA | 2008 | JMed Chem2008，51，5： | 1 |
| 4 | Discovery of dapagli- flozin : a potent, selective renal sodium-dependent glucose cotransporter 2 ( SGLT2 ) inhibitor for the treatment of type 2 diabetes 显示文摘 | Meng W Ellsworth BA Nirschl AA | 2008 | JMed Chem2008，1，5： | 1 |
| 5 | Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes显示文摘 | Meng W Ellsworth BA Nirschl AA | 2008 | JMed Chem2008，51，5： | 1 |
| 6 | Discovery of dapagliflozin: a po- tent, selective renal sodium-dependent glucose co-transporter 2 ( SGLT2 ) inhibitor for the treatment of type 2 diabetes 显示文摘 | WEI M ELLSWORTH BA | 2008 | JMed Chem2008，51，5： | 1 |
| 7 | Discovery of dapaglifloz- in:a potent, selective renal sodiumdependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes 显示文摘 | Meng W Ellsworth BA Nirschl AA | 2008 | J Med Chem2008，51，5： | 1 |
| 8 | Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2显示文摘 | Ellsworth BA Meng W Patel M | 2008 | Bioorg Med Chem Lett2008，18，17： | 1 |
| 9 | Discovery of dapagliflozin: a potent, selective renal sodium-dependent glu?cose cotransporter2 (SGLT2) inhibitor for the treatment of type 2 diabetes显示文摘 | MENG W ELLSWORTH BA NIRSCHL AA | 2008 | J Med Chem2008，51，5： | 1 |
| 10 | Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes显示文摘 | Meng W Ellsworth BA Nirschl AA | 2008 | J Med Chem2008，51，5： | 1 |
| 11 | Discovery of dapagliflozin : a potent, selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes 显示文摘 | WEI M ELLSWORTH BA | 2008 | J Med Chem2008，51，5： | 1 |
| 12 | Discovery of dapagliflozin: a potent, selec- tive renal sodium-dependent glucose co-transporter 2 (SGLT2) in- hibitor for the treatment of type 2 diabetes 显示文摘 | Wei M Ellsworth BA | 2008 | J Med Chem2008，51，5： | 1 |
| 13 | Discovery of dapagliflozin:a potent,selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes显示文摘 | Meng W Ellsworth BA Nirschl AA | 2008 | JMedChem2008，51，5： | 1 |
| 14 | Discovery of dapagliflozin: A polent, selective renal sodium-dependent glucose cotransporter 2 ( SGLT2 ) inhibitor for the treatment of type2 diabetes显示文摘 | MENG W ELLSWORTH BA ALEXANDRA A | 2008 | J Med Chem2008，51，5： | 1 |
| 15 | Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes 显示文摘 | Meng W Ellsworth BA Nirschl AA | 2008 | JMed Chem2008，51，5： | 1 |
| 16 | Discovery of dapaglifloz- in:a potent, selective renal sodium-dependent glucose cotransporter2 (SGLT2)inhibitor for the treatment of type 2 diabetes 显示文摘 | Meng W Ellsworth BA Nirschl AA | 2008 | J Med Chem2008，51，5： | 1 |
| 17 | Discovery of dapagliflozin:a potent,selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes显示文摘 | Meng W Ellsworth BA Nirschl AA | 2008 | J Med Chem2008，51，5： | 1 |
| 18 | Discovery of dapa-gliflozin: a poten,selective renal sodium-dependent glu-cose cotransporter2 ( SGLT2 ) inhibitor with dapagliflozinin type 2 diabetes mellitus显示文摘 | Meng W Ellsworth BA Nirschl AA | 2008 | Med Chem2008，51，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员